Could a simple blood thinner stop strokes before they start in heart disease patients?
NCT ID NCT07202897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the blood thinner rivaroxaban can prevent strokes, heart attacks, and death in people with hypertrophic cardiomyopathy (HCM) who have early signs of atrial damage but normal heart rhythm. About 532 adults aged 40-80 with HCM and reduced left atrial strain will be randomly assigned to rivaroxaban or a placebo. The goal is to see if early treatment can reduce serious events before atrial fibrillation develops.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Höpital la Pitié-Salpétrière
NOT_YET_RECRUITINGParis, France
-
APHM - Hôpital La Timone
NOT_YET_RECRUITINGMarseille, France
-
APHP Hopital Européen Georges Pompidou
NOT_YET_RECRUITINGParis, France
-
APHP, Hôpital Lariboisière
NOT_YET_RECRUITINGParis, France
-
CHU Angers
NOT_YET_RECRUITINGAngers, France
-
CHU Bordeaux Haut-Levêque
NOT_YET_RECRUITINGBordeaux, France
-
CHU Brest - Hôpital La Cavale Blanche
NOT_YET_RECRUITINGBrest, France
-
CHU Caen
NOT_YET_RECRUITINGCaen, France
-
CHU Dijon - Hôpital François Mitterrand
RECRUITINGDijon, France
-
CHU Grenoble Alpes
NOT_YET_RECRUITINGGrenoble, France
-
CHU Lille
NOT_YET_RECRUITINGLille, France
-
CHU Nancy
NOT_YET_RECRUITINGVandœuvre-lès-Nancy, France
-
CHU Rangueil Toulouse
NOT_YET_RECRUITINGToulouse, France
-
CHU Rennes - Hôpital Pontchaillou
RECRUITINGRennes, France
-
CHU de Nantes -Hôpital Nord Laennec
NOT_YET_RECRUITINGNantes, 44800, France
-
CHU de Rouen
NOT_YET_RECRUITINGRouen, 76000, France
-
CHU de TOURS - HOPITAL TROUSSEAU
NOT_YET_RECRUITINGTours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scan AI could predict sudden cardiac death risk in common heart condition
- Experimental pill aims to ease thick heart muscle symptoms
- Massive HCM database aims to unlock better heart care
- Heart drug swap tested for safer symptom control
- Real-World HCM drug use under the microscope
- Heart drug mavacamten shows promise in Real-World study